Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia (Q44639449)

4 December 2017

0 references

Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia (English)

1 reference

4 December 2017

0 references

0 references

1 reference

1

1 reference

4 December 2017

2

1 reference

4 December 2017

Tsuang MT

3

1 reference

PubMed ID

14593428

4 December 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

4 December 2017

1 reference

4 December 2017

8

1 reference

4 December 2017

911-915

1 reference

4 December 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.mp.4001321

4 December 2017

0 references

cites work

Dopamine receptors and the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

A structural polymorphism of human dopamine D2 receptor, D2(Ser311-->Cys).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

Functional analysis of the human D2 dopamine receptor missense variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

Dopamine DRD2/Cys311 is not associated with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

Association analysis between two functional dopamine D2 receptor gene polymorphisms and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

Dopamine D2 receptors in demented patients with severe neuroleptic sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

On estimating the relation between blood group and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

Meta-analysis of DRD3 gene and schizophrenia: ethnic heterogeneity and significant association in Caucasians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

No association of the Ser/Cys311 DRD2 molecular variant with schizophrenia using a classical case control study and the haplotype relative risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

Dopamine D2 receptor molecular variant and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

Association of dopamine D2 receptor molecular variant with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

7 January 2021

Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

7 January 2021

Ser-311-Cys polymorphism of the dopamine D2 receptor gene and schizophrenia--an analysis of schizophrenic patients in Fukuoka.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

7 January 2021

Mismatch PCR RFLP detection of DRD2 Ser311Cys polymorphism and schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

7 January 2021

An association study between the Cys311 variant of dopamine D2 receptor gene and schizophrenia in the Okinawan population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

7 January 2021

No major role for the dopamine D2 receptor Ser-->Cys311 mutation in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

7 January 2021

Polymorphisms of dopamine D2-like (D2, D3, and D4) receptors in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

7 January 2021

Dopamine receptor D2 Ser/Cys 311 variant is associated with delusion and disorganization symptomatology in major psychoses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

7 January 2021

S311C D2DR variant: no association with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

7 January 2021

Lack of association between dopamine D2 receptor gene Cys311 variant and schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

7 January 2021

No association of dopamine D2 receptor molecular variant Cys311 and schizophrenia in Chinese patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

7 January 2021

Polymorphism of dopamine receptors and transporter genes in neuropsychiatric diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

7 January 2021

European multicentre association study of schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

7 January 2021

No evidence for association of dopamine D2 receptor variant (Ser311/Cys311) with major psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001321

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4001321

1 reference

4 December 2017

1 reference

PubMed ID

14593428